Literature DB >> 12354785

Evidence for an inflammatory bowel disease locus on chromosome 3p26: linkage, transmission/disequilibrium and partitioning of linkage.

Richard H Duerr1, M Michael Barmada, Leilei Zhang, Jean-Paul Achkar, Judy H Cho, Stephen B Hanauer, Steven R Brant, Theodore M Bayless, Robert N Baldassano, Daniel E Weeks.   

Abstract

Crohn's disease and ulcerative colitis, the two major forms of idiopathic inflammatory bowel disease (IBD), are heritable, complex traits that appear to share some but not all susceptibility loci. We report that transmission/disequilibrium test analysis of a Crohn's disease genome scan dataset has detected an inflammatory bowel disease locus on chromosome 3p26 (nominal P=0.000052 and genome-wide corrected P=0.039 at D3S1297). An allele sharing method shows significant linkage (multipoint lod=3.69) in a larger, independent sample of inflammatory bowel disease-affected sibling pairs. A survey of 16 chromosome 3p26 short tandem repeat polymorphisms in a combined sample of 234 independent nuclear families with 324 IBD-affected sibling pairs shows significant linkage to chromosome 3p26 (multipoint lod=3.78) and significant transmission/disequilibrium test results at two adjacent markers (nominal P values in two different transmission/disequilibrium analysis methods=0.00011 and 0.0011 for the first marker, and 0.00071 and 0.00013 for the second marker). There is highly significant under-transmission of a common allele and modest over-transmission of other alleles at both markers. Families with no transmission to affected individuals of the under-transmitted alleles show significant linkage (multipoint lod=4.50) that is significantly greater in four simulation studies (P=0.0001, 0.0000625, 0.0000625 and 0.0000625, respectively) than the linkage evidence in families with transmission of the under-transmitted alleles (multipoint lod=0.12). Thus, the existence of an inflammatory bowel disease locus on chromosome 3p26 is supported by significant linkage, transmission/disequilibrium and partitioning of linkage evidence.

Entities:  

Mesh:

Year:  2002        PMID: 12354785     DOI: 10.1093/hmg/11.21.2599

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  10 in total

Review 1.  Novel susceptibility genes in inflammatory bowel disease.

Authors:  Colin Noble; Elaine Nimmo; Daniel Gaya; Richard K Russell; Jack Satsangi
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

Review 2.  NLR proteins: integral members of innate immunity and mediators of inflammatory diseases.

Authors:  Jeanette M Wilmanski; Tanja Petnicki-Ocwieja; Koichi S Kobayashi
Journal:  J Leukoc Biol       Date:  2007-09-17       Impact factor: 4.962

3.  Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1.

Authors:  Yun Zhao; Carmen Alonso; Isabel Ballester; Joo Hye Song; Sun Young Chang; Bayasi Guleng; Seiji Arihiro; Peter J Murray; Ramnik Xavier; Koichi S Kobayashi; Hans-Christian Reinecker
Journal:  Inflamm Bowel Dis       Date:  2011-09-01       Impact factor: 5.325

Review 4.  SAMP1/YitFc mouse strain: a spontaneous model of Crohn's disease-like ileitis.

Authors:  Theresa T Pizarro; Luca Pastorelli; Giorgos Bamias; Rekha R Garg; Brian K Reuter; Joseph R Mercado; Marcello Chieppa; Kristen O Arseneau; Klaus Ley; Fabio Cominelli
Journal:  Inflamm Bowel Dis       Date:  2011-05-06       Impact factor: 5.325

5.  Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis.

Authors:  P Goyette; C Lefebvre; A Ng; S R Brant; J H Cho; R H Duerr; M S Silverberg; K D Taylor; A Latiano; G Aumais; C Deslandres; G Jobin; V Annese; M J Daly; R J Xavier; J D Rioux
Journal:  Mucosal Immunol       Date:  2008-01-16       Impact factor: 7.313

Review 6.  Ste20-related proline/alanine-rich kinase: a novel regulator of intestinal inflammation.

Authors:  Yutao Yan; Didier Merlin
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

Review 7.  What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails?

Authors:  Ian C Lawrance
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

Review 8.  Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning.

Authors:  Chang-Qing Zheng; Gang-Zheng Hu; Zhao-Shu Zeng; Lian-Jie Lin; Gin-Ge Gu
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

Review 9.  Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: a systematic review.

Authors:  Isabelle Cleynen; Peter Jüni; Geertruida E Bekkering; Eveline Nüesch; Camila T Mendes; Stefanie Schmied; Stefan Wyder; Eliane Kellen; Peter M Villiger; Paul Rutgeerts; Séverine Vermeire; Daniel Lottaz
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

Review 10.  Uncovering Pathogenic Mechanisms of Inflammatory Bowel Disease Using Mouse Models of Crohn's Disease-Like Ileitis: What is the Right Model?

Authors:  Fabio Cominelli; Kristen O Arseneau; Alexander Rodriguez-Palacios; Theresa T Pizarro
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-03-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.